Methylation of the BRCA1 promoter along with the corresponding loss of BRCA1 expression in mutation-negative breast cancer is well described for both familial and sporadic breast cancer and has been demonstrated using low-throughput loci-specific methods [16–18]. Here, BRCA1 is linked to breast carcinoma.